Literature DB >> 24845419

Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.

Yun Teng1, Lacey M Litchfield1, Margarita M Ivanova1, Russell A Prough1, Barbara J Clark1, Carolyn M Klinge2.   

Abstract

Although oncomiR miR-21 is highly expressed in liver and overexpressed in hepatocellular carcinoma (HCC), its regulation is uncharacterized. We examined the effect of physiologically relevant nanomolar concentrations of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S) on miR-21 expression in HepG2 human hepatoma cells. 10nM DHEA and DHEA-S increase pri-miR-21 transcription in HepG2 cells. Dietary DHEA increased miR-21 in vivo in mouse liver. siRNA and inhibitor studies suggest that DHEA-S requires desulfation for activity and that DHEA-induced pri-miR-21 transcription involves metabolism to androgen and estrogen receptor (AR and ER) ligands. Activation of ERβ and AR by DHEA metabolites androst-5-ene-3,17-dione (ADIONE), androst-5-ene-3β,17β-diol (ADIOL), dihydrotestosterone (DHT), and 5α-androstane-3β,17β-diol (3β-Adiol) increased miR-21 transcription. DHEA-induced miR-21 increased cell proliferation and decreased Pdcd4 protein, a bona fide miR-21. Estradiol (E2) inhibited miR-21 expression via ERα. DHEA increased ERβ and AR recruitment to the miR-21 promoter within the VMP1/TMEM49 gene, with possible significance in hepatocellular carcinoma.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Androgen receptor; DHEA; Estrogen receptor; HepG2 cells; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24845419      PMCID: PMC4074919          DOI: 10.1016/j.mce.2014.05.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  116 in total

Review 1.  Metastamirs: a stepping stone towards improved cancer management.

Authors:  Nicole M A White; Eman Fatoohi; Maged Metias; Klaus Jung; Carsten Stephan; George M Yousef
Journal:  Nat Rev Clin Oncol       Date:  2010-11-02       Impact factor: 66.675

Review 2.  Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports.

Authors:  Laïla El Kihel
Journal:  Steroids       Date:  2011-10-02       Impact factor: 2.668

3.  Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Authors:  Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

4.  miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.

Authors:  Qin Zhu; Zhiming Wang; Yu Hu; Jindong Li; Xinying Li; Ledu Zhou; Yun Huang
Journal:  Oncol Rep       Date:  2012-02-09       Impact factor: 3.906

5.  MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Authors:  Longlong Bao; Yan Yan; Can Xu; Weidan Ji; Shuwen Shen; Gaoya Xu; Yong Zeng; Bin Sun; Haihua Qian; Lei Chen; Mengchao Wu; Changqing Su; Jie Chen
Journal:  Cancer Lett       Date:  2013-05-14       Impact factor: 8.679

6.  Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus.

Authors:  Enrico Sanna; Giuseppe Talani; Fabio Busonero; Maria Giuseppina Pisu; Robert H Purdy; Mariangela Serra; Giovanni Biggio
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

7.  Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms.

Authors:  Dongmin Liu; Mary Iruthayanathan; Laurie L Homan; Yiqiang Wang; Lingling Yang; Yao Wang; Joseph S Dillon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

8.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.

Authors:  Amelia A Peters; Grant Buchanan; Carmela Ricciardelli; Tina Bianco-Miotto; Margaret M Centenera; Jonathan M Harris; Shalini Jindal; Davendra Segara; Li Jia; Nicole L Moore; Susan M Henshall; Stephen N Birrell; Gerhard A Coetzee; Robert L Sutherland; Lisa M Butler; Wayne D Tilley
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

9.  Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells.

Authors:  Marita Pall; Margaret Nguyen; Denis Magoffin; Ricardo Azziz
Journal:  Fertil Steril       Date:  2008-06-12       Impact factor: 7.329

10.  Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes.

Authors:  Yasumasa Ikeda; Soichiro Tajima; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Keisuke Ishizawa; Shuhei Tomita; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more
  11 in total

1.  Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.

Authors:  Yun Teng; Brandie N Radde; Lacey M Litchfield; Margarita M Ivanova; Russell A Prough; Barbara J Clark; Mark A Doll; David W Hein; Carolyn M Klinge
Journal:  J Biol Chem       Date:  2015-05-11       Impact factor: 5.157

Review 2.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

Review 3.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

Review 4.  Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.

Authors:  Bodo C Melnik
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-07-15

5.  Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.

Authors:  Ivan Casaburi; Maria Grazia Cesario; Ada Donà; Pietro Rizza; Saveria Aquila; Paola Avena; Marilena Lanzino; Michele Pellegrino; Adele Vivacqua; Paola Tucci; Catia Morelli; Sebastiano Andò; Diego Sisci
Journal:  Oncotarget       Date:  2016-03-15

6.  Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Authors:  Minqian Shen; Haifei Shi
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

7.  Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells.

Authors:  Hui Ren; Bo Ren; Jiabin Zhang; Xiaofeng Zhang; Lixin Li; Lingzhan Meng; Zhijie Li; Jia Li; Yinjie Gao; Xuemei Ma
Journal:  Oncotarget       Date:  2017-11-25

Review 8.  Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis.

Authors:  Julia Jansen; Thomas Greither; Hermann M Behre
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

9.  A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.

Authors:  Minqian Shen; Mengyang Xu; Fanyi Zhong; McKenzie C Crist; Anjali B Prior; Kundi Yang; Danielle M Allaire; Fouad Choueiry; Jiangjiang Zhu; Haifei Shi
Journal:  Cells       Date:  2021-02-20       Impact factor: 6.600

Review 10.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.